4J Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
4J Wealth Management's ABBV Position: Q2 2026 in Review
4J Wealth Management reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $3.44K and leaving 1,377 shares worth $347K. The position accounts for 0.17% of the portfolio, ranked #76.
4J Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 16 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- 4J Wealth Management held 1,377 shares of AbbVie worth $347K as of Q2 2026.
- 4J Wealth Management sold 16 AbbVie shares in Q2 2026, an estimated $3.44K.
- AbbVie made up 0.17% of 4J Wealth Management's portfolio in Q2 2026, its #76 holding.
- 4J Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 16 quarters since.
- 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on 4J Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.